The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALECTOR INC | COM | 014442107 | 4,517,296 | 2,101,068 | SH | SOLE | 2,101,068 | 0 | 0 | |||
| ALKERMES PLC | SHS | G01767105 | 11,244,197 | 317,992 | SH | SOLE | 317,992 | 0 | 0 | |||
| ALUMIS INC | COM | 022307102 | 8,648,405 | 392,574 | SH | SOLE | 392,574 | 0 | 0 | |||
| ALTO NEUROSCIENCE INC | COM SHS | 02157Q109 | 29,116,321 | 1,325,210 | SH | SOLE | 1,325,210 | 0 | 0 | |||
| AN2 THERAPEUTICS INC | COM | 037326105 | 5,575,870 | 1,661,073 | SH | SOLE | 1,661,073 | 0 | 0 | |||
| CENTESSA PHARMACEUTICALS | SPONSORED ADS | 152309100 | 19,456,802 | 489,849 | SH | SOLE | 489,849 | 0 | 0 | |||
| CENTURY THERAPEUTICS | COM | 15673T100 | 9,173,462 | 4,059,054 | SH | SOLE | 4,059,054 | 0 | 0 | |||
| CORVUS PHARMACEUTICALS I | COM | 221015100 | 3,388,089 | 231,585 | SH | SOLE | 231,585 | 0 | 0 | |||
| DIANTHUS THERAPEUTICS IN | COM | 252828108 | 31,325,154 | 373,274 | SH | SOLE | 373,274 | 0 | 0 | |||
| ENANTA PHARMACEUTICALS I | COM | 29251M106 | 11,778,713 | 932,598 | SH | SOLE | 932,598 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 12,897,035 | 329,006 | SH | SOLE | 329,006 | 0 | 0 | |||
| ERASCA INC | COM | 29479A108 | 6,836,746 | 422,543 | SH | SOLE | 422,543 | 0 | 0 | |||
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | G4444S107 | 5,080,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| INHIBIKASE THERAPEUTI | COM NEW | 45719W205 | 6,017,093 | 3,581,603 | SH | SOLE | 3,581,603 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS | COM | 483497103 | 18,070,319 | 897,681 | SH | SOLE | 897,681 | 0 | 0 | |||
| KINIKSA PHARMACEUTICALS I | ORD SHS CL A | G52694109 | 36,645,183 | 761,063 | SH | SOLE | 761,063 | 0 | 0 | |||
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | 33,644,866 | 1,376,159 | SH | SOLE | 1,376,159 | 0 | 0 | |||
| LEONABIO INC | COM | 04746L203 | 3,844,884 | 393,701 | SH | SOLE | 393,701 | 0 | 0 | |||
| LEXEO THERAPEUTICS INC | COM | 52886X107 | 5,330,124 | 928,593 | SH | SOLE | 928,593 | 0 | 0 | |||
| MAZE THERAPEUTICS INC | COM | 578784100 | 5,970,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| MINERVA NEUROSCIENC | COM NEW | 603380205 | 9,974,388 | 1,655,500 | SH | SOLE | 1,655,500 | 0 | 0 | |||
| PERSPECTIVE THERAPEUTICS | COM NEW | 46489V302 | 10,955,036 | 2,627,107 | SH | SOLE | 2,627,107 | 0 | 0 | |||
| RELAY THERAPEUTICS INC | COM | 75943R102 | 29,692,044 | 2,984,125 | SH | SOLE | 2,984,125 | 0 | 0 | |||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 42,998,208 | 6,262,114 | SH | SOLE | 6,262,114 | 0 | 0 | |||
| SAB BIOTHERAPEUTICS IN | COM NEW | 78397T202 | 8,420,263 | 2,198,502 | SH | SOLE | 2,198,502 | 0 | 0 | |||
| SAVARA INC | COM | 805111101 | 18,472,136 | 3,383,175 | SH | SOLE | 3,383,175 | 0 | 0 | |||
| SURROZEN INC COM NEW | COM NEW | 86889P208 | 12,585,325 | 432,040 | SH | SOLE | 432,040 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 14,278,150 | 245,709 | SH | SOLE | 245,709 | 0 | 0 | |||